CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 65 enrolled
Drug / intervention
Receiver in the canal (RIC) hearing aidsdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03904264
NCT03904264N/ACompleted

Feasibility and Acceptability of Using Low-Gain Hearing Aids for Bothersome Tinnitus

VA Office of Research and Development·interventional·Posted Apr 5, 2019·Updated Nov 21, 2023

In Brief

A clinical study evaluating Receiver in the canal (RIC) hearing aids for Tinnitus and 2 related conditions. Completed, enrolled 65 participants across 1 site.

Detailed Summary

Tinnitus - defined as ringing, humming, or other sounds in the ears or head - is a very common problem for Veterans. Hearing aids that deliver low-level amplification are being used by audiologists to help people with tinnitus who also have normal hearing. However, there is a lack of research evidence showing that this practice is effective. Despite this fact, the practice clearly is spreading. Reports from audiologists in the field as well as research presentations refer to hearing aids being used in this way. Use of hearing aids has been shown to reduce distress from tinnitus for people with hearing loss. Additionally, the use of external sound to help reduce the impact of tinnitus has been shown to be effective. There is clearly a gap in the research regarding the use of hearing aids as a therapeutic method to manage tinnitus when hearing is considered normal. This study will obtain pilot data evaluating people with normal hearing and bothersome tinnitus to find out whether low-level amplification through hearing aids may provide benefit.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedApr 5, 2019
Enrollment StartFeb 24, 2020
Primary CompletionSep 30, 2022
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 7.2 years ago

Interventions

Receiver in the canal (RIC) hearing aidsdevice

The RIC hearing aids fitted to subjects in arm 1 of the study will be manufactured by Widex.